/Investor DB

Qiming Venture Partners — 2026 Investments

6 investments dated 2026 · listed companies and verified rows first · show all

Zai Labzailaboratory.comin𝕏NASDAQ: ZLABOct 2026

Zai Lab is a global biopharmaceutical company developing and commercializing therapies in oncology, immunology, neuroscience, and infectious disease, with operations in China and the United States.

BiotechHealthtechMedical Devices

Samantha (Ying) Du(Founder, Chief Executive Officer, Chairperson of the Board of Directors)inYajing Chen(Chief Financial Officer)inRafael G. Amado(President, Head of Global Research and Development)inF. Ty Edmondson(Chief Legal Officer)inJosh Smiley(President and Chief Operating Officer)Samantha Du(Founder)

Co-investorsVivo CapitalYuanBio Venture CapitalAdvantech CapitalHongShan Capital GroupKleiner PerkinsSequoia Capital

Apollomicsapollomicsinc.comin𝕏Aug 2026

Apollomics is a biotechnology company focused on discovering and developing oncology therapies designed to combine with other treatments, using approaches that engage the immune system and target specific molecular pathways to inhibit cancer.

BiotechHealthtechFoster City, US

Peter Lin(Executive Officer)Guo-Liang Yu(Founder)Sanjeev Redkar(Founder)

BoardHung-Wen (Howard) Chen(Executive Officer, Director)Hung-Hsien Yen(Director)Yi-Kuei (Alex) Chen(Executive Officer, Director)

Co-investorsMaxpro VenturesPan-Lin CapitalSVE CapitalK2VC

Entact Bioentactbio.comJan 2026

Entact is a drug discovery company developing treatments for patients.

BiotechDeep TechWatertown, US

Victoria Richon(Executive Officer, Director, Promoter)inRuben Tommasi(Chief Scientific Officer)Michael Gutch(Chief Operating Officer)Alon Lazarus(Director)Ueli (Ulrich) Nachbur(Founder)Sylvie Urbe(Founder)

Co-investorsvenBio PartnersAbingworthArkin CapitalvenBio Global Strategic

RMBrmbventures.co.zain𝕏Sep 2026

RMB Ventures is a private equity firm that invests across all sectors of the economy except primary mining and passive real estate, with selective agricultural sector participation.

Enterprise SoftwareSector AgnosticJohannesburg, ZA

Co-investorsAfrica Climate VenturesAlibaba GroupHongShan Capital GroupShenzhen Capital GroupTencent Holdings

Sharpasharpa.comSep 2026

Sharpa builds humanoid robotics hardware, including the D01 system that combines a dexterous Wave hand, 7-DoF arms, whole-body tactile E-skin, and a teleoperation system for complex physical tasks.

Deep TechHardwareRobotics

Co-investorsB Capital GroupAlibaba GroupHongShan Capital GroupOutsized VenturesTencent Holdings

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Dongsheng Fusion

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.